Neuronal cytoskeletal alterations evoked by a platelet-activating factor (PAF) analogue

Platelet‐activating factor (PAF), a phospholipid signaling molecule found in brain, modulates several neural functions and is implicated in the human developmental brain disorder Miller‐Dieker Lissencephaly (MDL). Exposure to PAF, and a non‐hydrolyzable analogue, methyl carbamyl PAF (mc‐PAF), produc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cell motility and the cytoskeleton 1999, Vol.43 (2), p.99-113
Hauptverfasser: McNeil, R.S., Swann, J.W., Brinkley, B.R., Clark, G.D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 113
container_issue 2
container_start_page 99
container_title Cell motility and the cytoskeleton
container_volume 43
creator McNeil, R.S.
Swann, J.W.
Brinkley, B.R.
Clark, G.D.
description Platelet‐activating factor (PAF), a phospholipid signaling molecule found in brain, modulates several neural functions and is implicated in the human developmental brain disorder Miller‐Dieker Lissencephaly (MDL). Exposure to PAF, and a non‐hydrolyzable analogue, methyl carbamyl PAF (mc‐PAF), produces the following rapid, reversible effects upon cultured hippocampal neurites: growth cone collapse, neurite retraction, and neurite varicosity formation. In this study, the cytoskeletal alterations that mediate these shape changes were investigated by comparing the effects of mc‐PAF with other cytoskeletal‐altering drugs, through the fluorescent labeling of cytoskeletal proteins and mitochondria, and by electron microscopy. Results indicate that rearrangments of microtubules (MTs), F‐actin, and mitochondria underlie the neurite shape changes produced by mc‐PAF. Evidence for MT alteration was obtained by comparing the effects of mc‐PAF with nocodozole and taxol. Exposure to nocodazole, a MT‐depolymerizing agent, produced growth cone collapse and neurite varicosity formation similar to mc‐PAF, whereas pre‐incubation of neurites in taxol, a MT‐stabilizing drug, was effective in blocking mc‐PAF‐induced neurite effects. Immunofluorescent labeling and EM revealed MT splaying and unbundling within neurite varicosities following mc‐PAF treatment. Immunofluorescent labeling also revealed that F‐actin shifted from concentration in the growth cone to a diffuse distribution along the neurite shaft following mc‐PAF exposure. Fluorescent labeling and EM also revealed retrograde movement and morphological alterations of mitochondria following mc‐PAF exposure, resulting in mitochondrial aggregates within neurite varicosities. These cytoskeletal rearrangements may provide insights into the mechanisms by which PAF influences neuronal activity, and could have important implications for the impairment of neuronal motility observed in MDL. Cell Motil. Cytoskeleton 43:99–113, 1999. © 1999 Wiley‐Liss, Inc.
doi_str_mv 10.1002/(SICI)1097-0169(1999)43:2<99::AID-CM2>3.0.CO;2-W
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69838696</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69838696</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3902-2fc9c5b2685cd97998491dfecd06895c86098c7141b04db0255f5ceebfbdbc0d3</originalsourceid><addsrcrecordid>eNp9kNFq2zAUhsXYWLNurzB8NZILZ0eWZetkZRC8Ngt0TUe3BXZzkGW5eHHizLLb5e0nk1IGhV0dHfHx_5yPMcVhygGi9-ObZbaccMA0BJ7gmCPiJBaz6AxxNpsvP4XZl-ijmMI0W32IwvUzNnqEn7MRKJWEXMbxCXvl3C8AzuNUvmQnHESKSsgRW1_Zvm12ug7MoWvcxta284uuO9vqrmp2LrB3zcYWQX4IdLCvdTcgoTZddeeB3W1Q-nfTBuPr-cUk0D6que3ta_ai1LWzbx7mKft-cf4t-xxerhbLbH4ZGoEQhVFp0Mg8SpQ0BaaIKkZelNYUkCiURiWAyqQ85jnERQ6RlKU01uZlXuQGCnHK3h1z923zu7euo23ljK1rvbNN7yjxZ6oEEw9eH0HTNs61tqR9W211eyAONMgmGmTT4I8GfzTIplhQRH6Sl01eNgkCylb-c-0j3z509_nWFv8EHu16YHUE7qvaHp4U_q_vad2w-sTwmFi5zv55TNTthpJUpJLWVwv6eZMC_vi6IBR_AUAcp_g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69838696</pqid></control><display><type>article</type><title>Neuronal cytoskeletal alterations evoked by a platelet-activating factor (PAF) analogue</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>McNeil, R.S. ; Swann, J.W. ; Brinkley, B.R. ; Clark, G.D.</creator><creatorcontrib>McNeil, R.S. ; Swann, J.W. ; Brinkley, B.R. ; Clark, G.D.</creatorcontrib><description>Platelet‐activating factor (PAF), a phospholipid signaling molecule found in brain, modulates several neural functions and is implicated in the human developmental brain disorder Miller‐Dieker Lissencephaly (MDL). Exposure to PAF, and a non‐hydrolyzable analogue, methyl carbamyl PAF (mc‐PAF), produces the following rapid, reversible effects upon cultured hippocampal neurites: growth cone collapse, neurite retraction, and neurite varicosity formation. In this study, the cytoskeletal alterations that mediate these shape changes were investigated by comparing the effects of mc‐PAF with other cytoskeletal‐altering drugs, through the fluorescent labeling of cytoskeletal proteins and mitochondria, and by electron microscopy. Results indicate that rearrangments of microtubules (MTs), F‐actin, and mitochondria underlie the neurite shape changes produced by mc‐PAF. Evidence for MT alteration was obtained by comparing the effects of mc‐PAF with nocodozole and taxol. Exposure to nocodazole, a MT‐depolymerizing agent, produced growth cone collapse and neurite varicosity formation similar to mc‐PAF, whereas pre‐incubation of neurites in taxol, a MT‐stabilizing drug, was effective in blocking mc‐PAF‐induced neurite effects. Immunofluorescent labeling and EM revealed MT splaying and unbundling within neurite varicosities following mc‐PAF treatment. Immunofluorescent labeling also revealed that F‐actin shifted from concentration in the growth cone to a diffuse distribution along the neurite shaft following mc‐PAF exposure. Fluorescent labeling and EM also revealed retrograde movement and morphological alterations of mitochondria following mc‐PAF exposure, resulting in mitochondrial aggregates within neurite varicosities. These cytoskeletal rearrangements may provide insights into the mechanisms by which PAF influences neuronal activity, and could have important implications for the impairment of neuronal motility observed in MDL. Cell Motil. Cytoskeleton 43:99–113, 1999. © 1999 Wiley‐Liss, Inc.</description><identifier>ISSN: 0886-1544</identifier><identifier>EISSN: 1097-0169</identifier><identifier>DOI: 10.1002/(SICI)1097-0169(1999)43:2&lt;99::AID-CM2&gt;3.0.CO;2-W</identifier><identifier>PMID: 10379835</identifier><language>eng</language><publisher>New York: John Wiley &amp; Sons, Inc</publisher><subject>actin ; Actins - metabolism ; Animals ; Cells, Cultured ; Cytochalasin D - pharmacology ; Cytoskeleton - drug effects ; Cytoskeleton - physiology ; Cytoskeleton - ultrastructure ; Fluorescent Antibody Technique, Indirect ; microtubule motors ; microtubules ; Microtubules - drug effects ; Microtubules - physiology ; mitochondria ; Mitochondria - drug effects ; Mitochondria - physiology ; neurite shape changes ; Neurites - drug effects ; Neurites - ultrastructure ; Neurons - drug effects ; Neurons - physiology ; Neurons - ultrastructure ; Nocodazole - pharmacology ; Paclitaxel - pharmacology ; Phospholipid Ethers - chemistry ; Phospholipid Ethers - pharmacology ; Platelet Activating Factor - analogs &amp; derivatives ; Polymers ; Rats ; Rats, Sprague-Dawley</subject><ispartof>Cell motility and the cytoskeleton, 1999, Vol.43 (2), p.99-113</ispartof><rights>Copyright © 1999 Wiley‐Liss, Inc.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3902-2fc9c5b2685cd97998491dfecd06895c86098c7141b04db0255f5ceebfbdbc0d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F%28SICI%291097-0169%281999%2943%3A2%3C99%3A%3AAID-CM2%3E3.0.CO%3B2-W$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F%28SICI%291097-0169%281999%2943%3A2%3C99%3A%3AAID-CM2%3E3.0.CO%3B2-W$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,4010,27900,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10379835$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McNeil, R.S.</creatorcontrib><creatorcontrib>Swann, J.W.</creatorcontrib><creatorcontrib>Brinkley, B.R.</creatorcontrib><creatorcontrib>Clark, G.D.</creatorcontrib><title>Neuronal cytoskeletal alterations evoked by a platelet-activating factor (PAF) analogue</title><title>Cell motility and the cytoskeleton</title><addtitle>Cell Motil. Cytoskeleton</addtitle><description>Platelet‐activating factor (PAF), a phospholipid signaling molecule found in brain, modulates several neural functions and is implicated in the human developmental brain disorder Miller‐Dieker Lissencephaly (MDL). Exposure to PAF, and a non‐hydrolyzable analogue, methyl carbamyl PAF (mc‐PAF), produces the following rapid, reversible effects upon cultured hippocampal neurites: growth cone collapse, neurite retraction, and neurite varicosity formation. In this study, the cytoskeletal alterations that mediate these shape changes were investigated by comparing the effects of mc‐PAF with other cytoskeletal‐altering drugs, through the fluorescent labeling of cytoskeletal proteins and mitochondria, and by electron microscopy. Results indicate that rearrangments of microtubules (MTs), F‐actin, and mitochondria underlie the neurite shape changes produced by mc‐PAF. Evidence for MT alteration was obtained by comparing the effects of mc‐PAF with nocodozole and taxol. Exposure to nocodazole, a MT‐depolymerizing agent, produced growth cone collapse and neurite varicosity formation similar to mc‐PAF, whereas pre‐incubation of neurites in taxol, a MT‐stabilizing drug, was effective in blocking mc‐PAF‐induced neurite effects. Immunofluorescent labeling and EM revealed MT splaying and unbundling within neurite varicosities following mc‐PAF treatment. Immunofluorescent labeling also revealed that F‐actin shifted from concentration in the growth cone to a diffuse distribution along the neurite shaft following mc‐PAF exposure. Fluorescent labeling and EM also revealed retrograde movement and morphological alterations of mitochondria following mc‐PAF exposure, resulting in mitochondrial aggregates within neurite varicosities. These cytoskeletal rearrangements may provide insights into the mechanisms by which PAF influences neuronal activity, and could have important implications for the impairment of neuronal motility observed in MDL. Cell Motil. Cytoskeleton 43:99–113, 1999. © 1999 Wiley‐Liss, Inc.</description><subject>actin</subject><subject>Actins - metabolism</subject><subject>Animals</subject><subject>Cells, Cultured</subject><subject>Cytochalasin D - pharmacology</subject><subject>Cytoskeleton - drug effects</subject><subject>Cytoskeleton - physiology</subject><subject>Cytoskeleton - ultrastructure</subject><subject>Fluorescent Antibody Technique, Indirect</subject><subject>microtubule motors</subject><subject>microtubules</subject><subject>Microtubules - drug effects</subject><subject>Microtubules - physiology</subject><subject>mitochondria</subject><subject>Mitochondria - drug effects</subject><subject>Mitochondria - physiology</subject><subject>neurite shape changes</subject><subject>Neurites - drug effects</subject><subject>Neurites - ultrastructure</subject><subject>Neurons - drug effects</subject><subject>Neurons - physiology</subject><subject>Neurons - ultrastructure</subject><subject>Nocodazole - pharmacology</subject><subject>Paclitaxel - pharmacology</subject><subject>Phospholipid Ethers - chemistry</subject><subject>Phospholipid Ethers - pharmacology</subject><subject>Platelet Activating Factor - analogs &amp; derivatives</subject><subject>Polymers</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><issn>0886-1544</issn><issn>1097-0169</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kNFq2zAUhsXYWLNurzB8NZILZ0eWZetkZRC8Ngt0TUe3BXZzkGW5eHHizLLb5e0nk1IGhV0dHfHx_5yPMcVhygGi9-ObZbaccMA0BJ7gmCPiJBaz6AxxNpsvP4XZl-ijmMI0W32IwvUzNnqEn7MRKJWEXMbxCXvl3C8AzuNUvmQnHESKSsgRW1_Zvm12ug7MoWvcxta284uuO9vqrmp2LrB3zcYWQX4IdLCvdTcgoTZddeeB3W1Q-nfTBuPr-cUk0D6que3ta_ai1LWzbx7mKft-cf4t-xxerhbLbH4ZGoEQhVFp0Mg8SpQ0BaaIKkZelNYUkCiURiWAyqQ85jnERQ6RlKU01uZlXuQGCnHK3h1z923zu7euo23ljK1rvbNN7yjxZ6oEEw9eH0HTNs61tqR9W211eyAONMgmGmTT4I8GfzTIplhQRH6Sl01eNgkCylb-c-0j3z509_nWFv8EHu16YHUE7qvaHp4U_q_vad2w-sTwmFi5zv55TNTthpJUpJLWVwv6eZMC_vi6IBR_AUAcp_g</recordid><startdate>1999</startdate><enddate>1999</enddate><creator>McNeil, R.S.</creator><creator>Swann, J.W.</creator><creator>Brinkley, B.R.</creator><creator>Clark, G.D.</creator><general>John Wiley &amp; Sons, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1999</creationdate><title>Neuronal cytoskeletal alterations evoked by a platelet-activating factor (PAF) analogue</title><author>McNeil, R.S. ; Swann, J.W. ; Brinkley, B.R. ; Clark, G.D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3902-2fc9c5b2685cd97998491dfecd06895c86098c7141b04db0255f5ceebfbdbc0d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>actin</topic><topic>Actins - metabolism</topic><topic>Animals</topic><topic>Cells, Cultured</topic><topic>Cytochalasin D - pharmacology</topic><topic>Cytoskeleton - drug effects</topic><topic>Cytoskeleton - physiology</topic><topic>Cytoskeleton - ultrastructure</topic><topic>Fluorescent Antibody Technique, Indirect</topic><topic>microtubule motors</topic><topic>microtubules</topic><topic>Microtubules - drug effects</topic><topic>Microtubules - physiology</topic><topic>mitochondria</topic><topic>Mitochondria - drug effects</topic><topic>Mitochondria - physiology</topic><topic>neurite shape changes</topic><topic>Neurites - drug effects</topic><topic>Neurites - ultrastructure</topic><topic>Neurons - drug effects</topic><topic>Neurons - physiology</topic><topic>Neurons - ultrastructure</topic><topic>Nocodazole - pharmacology</topic><topic>Paclitaxel - pharmacology</topic><topic>Phospholipid Ethers - chemistry</topic><topic>Phospholipid Ethers - pharmacology</topic><topic>Platelet Activating Factor - analogs &amp; derivatives</topic><topic>Polymers</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><toplevel>online_resources</toplevel><creatorcontrib>McNeil, R.S.</creatorcontrib><creatorcontrib>Swann, J.W.</creatorcontrib><creatorcontrib>Brinkley, B.R.</creatorcontrib><creatorcontrib>Clark, G.D.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cell motility and the cytoskeleton</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McNeil, R.S.</au><au>Swann, J.W.</au><au>Brinkley, B.R.</au><au>Clark, G.D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neuronal cytoskeletal alterations evoked by a platelet-activating factor (PAF) analogue</atitle><jtitle>Cell motility and the cytoskeleton</jtitle><addtitle>Cell Motil. Cytoskeleton</addtitle><date>1999</date><risdate>1999</risdate><volume>43</volume><issue>2</issue><spage>99</spage><epage>113</epage><pages>99-113</pages><issn>0886-1544</issn><eissn>1097-0169</eissn><abstract>Platelet‐activating factor (PAF), a phospholipid signaling molecule found in brain, modulates several neural functions and is implicated in the human developmental brain disorder Miller‐Dieker Lissencephaly (MDL). Exposure to PAF, and a non‐hydrolyzable analogue, methyl carbamyl PAF (mc‐PAF), produces the following rapid, reversible effects upon cultured hippocampal neurites: growth cone collapse, neurite retraction, and neurite varicosity formation. In this study, the cytoskeletal alterations that mediate these shape changes were investigated by comparing the effects of mc‐PAF with other cytoskeletal‐altering drugs, through the fluorescent labeling of cytoskeletal proteins and mitochondria, and by electron microscopy. Results indicate that rearrangments of microtubules (MTs), F‐actin, and mitochondria underlie the neurite shape changes produced by mc‐PAF. Evidence for MT alteration was obtained by comparing the effects of mc‐PAF with nocodozole and taxol. Exposure to nocodazole, a MT‐depolymerizing agent, produced growth cone collapse and neurite varicosity formation similar to mc‐PAF, whereas pre‐incubation of neurites in taxol, a MT‐stabilizing drug, was effective in blocking mc‐PAF‐induced neurite effects. Immunofluorescent labeling and EM revealed MT splaying and unbundling within neurite varicosities following mc‐PAF treatment. Immunofluorescent labeling also revealed that F‐actin shifted from concentration in the growth cone to a diffuse distribution along the neurite shaft following mc‐PAF exposure. Fluorescent labeling and EM also revealed retrograde movement and morphological alterations of mitochondria following mc‐PAF exposure, resulting in mitochondrial aggregates within neurite varicosities. These cytoskeletal rearrangements may provide insights into the mechanisms by which PAF influences neuronal activity, and could have important implications for the impairment of neuronal motility observed in MDL. Cell Motil. Cytoskeleton 43:99–113, 1999. © 1999 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>10379835</pmid><doi>10.1002/(SICI)1097-0169(1999)43:2&lt;99::AID-CM2&gt;3.0.CO;2-W</doi><tpages>15</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0886-1544
ispartof Cell motility and the cytoskeleton, 1999, Vol.43 (2), p.99-113
issn 0886-1544
1097-0169
language eng
recordid cdi_proquest_miscellaneous_69838696
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects actin
Actins - metabolism
Animals
Cells, Cultured
Cytochalasin D - pharmacology
Cytoskeleton - drug effects
Cytoskeleton - physiology
Cytoskeleton - ultrastructure
Fluorescent Antibody Technique, Indirect
microtubule motors
microtubules
Microtubules - drug effects
Microtubules - physiology
mitochondria
Mitochondria - drug effects
Mitochondria - physiology
neurite shape changes
Neurites - drug effects
Neurites - ultrastructure
Neurons - drug effects
Neurons - physiology
Neurons - ultrastructure
Nocodazole - pharmacology
Paclitaxel - pharmacology
Phospholipid Ethers - chemistry
Phospholipid Ethers - pharmacology
Platelet Activating Factor - analogs & derivatives
Polymers
Rats
Rats, Sprague-Dawley
title Neuronal cytoskeletal alterations evoked by a platelet-activating factor (PAF) analogue
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T17%3A41%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neuronal%20cytoskeletal%20alterations%20evoked%20by%20a%20platelet-activating%20factor%20(PAF)%20analogue&rft.jtitle=Cell%20motility%20and%20the%20cytoskeleton&rft.au=McNeil,%20R.S.&rft.date=1999&rft.volume=43&rft.issue=2&rft.spage=99&rft.epage=113&rft.pages=99-113&rft.issn=0886-1544&rft.eissn=1097-0169&rft_id=info:doi/10.1002/(SICI)1097-0169(1999)43:2%3C99::AID-CM2%3E3.0.CO;2-W&rft_dat=%3Cproquest_cross%3E69838696%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69838696&rft_id=info:pmid/10379835&rfr_iscdi=true